Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StaphVAX in Orthopedic Prosthetic Implant Patients
NCT00211965Phase 3Completed
- Sponsor
- Nabi Biopharmaceuticals
- Start
- Apr 2005
- Primary completion
- May 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Staphylococcus aureus infection comparing StaphVAX with Placebo (2 arms). Primary endpoint: Sero-type specific antibody concentrations at 6 weeks. Started Apr 2005; status: completed.
02
Drugs
s. aureus type 5 & 8 capsular polysaccharide vaccine
03
Conditions
Staphylococcus aureus infection
Beyond the preview
Go deeper on NCT00211965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00211965.